机译:MiR-21是从未吸烟者肺癌中EGFR调节的抗凋亡因子
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Department of Pulmonary Medicine/Infection and Oncology, Nippon Medical School, Tokyo 113-8602, Japan;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Department of Pulmonary Medicine/Infection and Oncology, Nippon Medical School, Tokyo 113-8602, Japan;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Division of Pulmonary and Critical Care Medicine and Microarray Share Resources, Mayo Clinic and Foundation, Rochester, MN 55905;
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905;
Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan;
Department of Pulmonary Medicine/Infection and Oncology, Nippon Medical School, Tokyo 113-8602, Japan;
Department of Pulmonary Medicine/Infection and Oncology, Nippon Medical School, Tokyo 113-8602, Japan;
Molecular Virology, Immunology and Medical Genetics, Ohio State University Comprehensive Cancer Center, Columbus, OH 43212;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
apoptosis; microRNA; microarray; EGFR-TKI; therapeutic target;
机译:“从不吸烟”的肺癌:分子因素胜过危险因素。
机译:从不吸烟的肺癌风险:环境和遗传因素概述
机译:康哈兰全国医院男性从不吸烟的肺癌危险因素
机译:bcl-2抗凋亡癌蛋白抑制非小细胞肺癌的血管生成:对光动力治疗的抵抗性有何影响?
机译:癌症预防研究-II,肺癌死亡率的环境危险因素。
机译:MiR-21是从未吸烟者肺癌中EGFR调节的抗凋亡因子
机译:MiR-21是从未吸烟者肺癌中EGFR调节的抗凋亡因子